Evidence gap analysis
Strategic analysis of the sufficiency of evidence to obtain reimbursement and HTA approval in Europe and recommendations about evidence generation
Recent news and posts
Dutch Healthcare Authority published the second release of the 2025 DRG package
On October 01, 2024, the Dutch Healthcare Authority (NZa) published the second release of the 2025 DRG package (RZ25b) that applies to specialist medical care and geriatric rehabilitation care. It includes three new procedure codes, four new supplementary payments (OZPs), 18 new diagnosis codes, and two new DRGs.
Some examples of new procedure codes include:
- Code 033974 “Plastic correction of breast deformity by autologous fat transplantation after previous breast reconstruction or breast-conserving surgery”;
- Code 034679 “Ultrasound of the intestines to measure wall thickness and assess the degree of inflammation”.
Four new supplementary payments (OZPs) will be implemented for molecular diagnostics, proactive palliative care planning, and extracorporeal treatment. Some examples of new OZP codes include:
- Code 050548 “Pathological examination - complex whole genome molecular diagnostics (WGS)”;
- Code 192161 “Normothermic regional perfusion (NRP) of donor abdominal organs in DCD liver transplantation”.
Two new DRGs will be implemented for ultrasound of the intestines in chronic inflammation of the colon (Crohn's disease or ulcerative colitis).
The effective date of the release is January 1, 2025.
See more information in Dutch here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.